Education
About Us
Working with TipRanks
Follow Us
T2 Biosystems (TTOO)
OTHER OTC:TTOO
TTOO Stock Chart & Stats
$0.01
-$0.01(-3.56%)
At close: 4:00 PM EST
$0.01
-$0.01(-3.56%)
Day’s Range― - ―
52-Week Range$0.00 - $0.56
Previous CloseN/A
Volume266.95K
Average Volume (3M)18.99K
Market Cap
$420.68K
Enterprise ValueN/A
Total Cash (Recent Filing)$2.08M
Total Debt (Recent Filing)$18.94M
Price to Earnings (P/E)―
Beta-5.23
Next Earnings
Nov 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding28,045,418
10 Day Avg. Volume30,842
30 Day Avg. Volume18,993
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.58
Price to Sales (P/S)2.28
P/FCF Ratio-0.34
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.19
Revenue Forecast (FY)$23.13M
T2 Biosystems News
TTOO FAQ
What was T2 Biosystems’s price range in the past 12 months?
T2 Biosystems lowest stock price was $0.00 and its highest was $0.56 in the past 12 months.
What is T2 Biosystems’s market cap?
T2 Biosystems’s market cap is $420.68K.
When is T2 Biosystems’s upcoming earnings report date?
T2 Biosystems’s upcoming earnings report date is Nov 06, 2025 which is 33 days ago.
How were T2 Biosystems’s earnings last quarter?
Currently, no data Available
Is T2 Biosystems overvalued?
According to Wall Street analysts T2 Biosystems’s price is currently Overvalued.
Does T2 Biosystems pay dividends?
T2 Biosystems does not currently pay dividends.
What is T2 Biosystems’s EPS estimate?
T2 Biosystems’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does T2 Biosystems have?
T2 Biosystems has 28,045,418 shares outstanding.
What happened to T2 Biosystems’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of T2 Biosystems?
Currently, no hedge funds are holding shares in TTOO
Company Description
T2 Biosystems
T2 Biosystems (TTOO) is a biotechnology company that specializes in developing innovative diagnostic products to improve patient outcomes and reduce healthcare costs. The company focuses on infectious diseases and aims to provide rapid and accurate diagnostic information to healthcare providers. T2 Biosystems offers a range of products, including the T2Dx Instrument and various panels such as the T2Bacteria and T2Candida Panels, which help in the timely detection of sepsis-causing pathogens directly from whole blood samples.
Technical Analysis
Ownership Overview
0.09%
Insiders
<0.01% Other Institutional Investors
99.91% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---